Skull Clamps Prompt Government Safety Warning

There were more than 700 injuries attributed to the medical device.

The FDA has received more than 1,000 medical device reports associated with the slippage, or movement, of a skull clamp before and/or during surgical procedures, resulting in more than 700 injuries from January 2009 to January 2016.

While they still believe the overall benefits of these devices continue to outweigh the risks, they are advising healthcare providers that they should be aware of patient-specific characteristics, techniques for safe use and maintenance of neurosurgical head holder systems to prevent skull clamps from slipping before and/or during surgical procedures.

The FDA’s review of medical literature and analysis of currently available data suggests that device slippage is not specific to any manufacturer or brand of devices.

The recommendations were relayed through a recent safety communication.

Reported injuries included skull fractures, facial injuries consisting of bruises and cuts, lacerations and blood clots.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report